Hypercytokinaemia observed in severe COVID-19 cases is characterized by increased plasma levels of pro-inflammatory cytokines.5 Thus, interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-1β, and IL-10 proteins in the plasma of patients were quantified using Simoa ELISA assay. This evidence concerns the gene IL6 and COVID-19.